Published March 14, 2024 | Version v1
Journal article Open

Antibody Characterization Report for CaMK-II subunit delta (CAMK2D)

  • 1. ROR icon Montreal Neurological Institute and Hospital
  • 2. ROR icon McGill University
  • 3. Advanced BioImaging Facility (ABIF)
  • 4. The Neuro's Early Drug Discovery Unit (EDDU)

Description

This report presents a guide to selecting high-quality commercial antibodies against CaMK-II subunit delta (CAMK2D) by Western blot, immunoprecipitation and immunofluorescence, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls.

The work presented in this study was supported in part by the Michael J. Fox Foundation for Parkinson's research.

Files

CaMK-II subunit delta_CAMK2D_YCharOS report.pdf

Files (4.7 MB)

Additional details

Dates

Submitted
2024-03-14